Synthesis of some novel heterocyclic and schiff base derivatives as antimicrobial agents

Azab, Mohamed E.; Rizk, Sameh Ahmed; Amr, Abd El-Galil E.;

Abstract


Treatment of 2,3-diaryloxirane-2,3-dicarbonitriles 1a-c with different nitrogen nucleophiles, e.g., hydrazine, methyl hydrazine, phenyl hydrazine, hydroxylamine, thiosemicarbazide, and/or 2-amino-5-phenyl-1,3,4-thiadiazole, afforded pyrazole, isoxazole, pyrrolotriazine, imidazolothiadiazole derivatives 2-5, respectively. Reacting pyrazoles 2a-c with aromatic aldehydes and/or methyl glycinate produced Schiff's bases 7a-d and pyrazolo[3,4-b]-pyrazinone derivative 8, respectively. Treating 7 with ammonium acetate and/or hydrazine hydrate, furnished the imidazolopyrazole and pyrazolotriazine derivatives 9 and 10, respectively. Reaction of 8 with chloroacetic acid and/or diethyl malonate gave tricyclic compound 11 and triketone 12, respectively. On the other hand, compound 1 was reacted with active methylene precursors, e.g., acetylacetone and/or cyclopentanone producing adducts 14a,b which upon fusion with ammonium acetate furnished the 3-pyridone derivatives 15a,b, respectively. Some of newly synthesized compounds were screened for activity against bacterial and fungal strains and most of the newly synthesized compounds showed high antimicrobial activities. The structures of the new compounds were elucidated using IR, 1H-NMR, 13C-NMR and mass spectroscopy.


Other data

Title Synthesis of some novel heterocyclic and schiff base derivatives as antimicrobial agents
Authors Azab, Mohamed E.; Rizk, Sameh Ahmed ; Amr, Abd El-Galil E. 
Keywords Antimicrobial activities;Isoxazole;Oxirane;Pyrazole;Pyrazolopyrazine;Pyridones;Schiff bases
Issue Date 7-Oct-2015
Journal Molecules 
Volume 20
Issue 10
Start page 18201
End page 18218
ISSN 1420-3049
DOI 10.3390/molecules201018201
PubMed ID 26457697
Scopus ID 2-s2.0-84946151864

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check



Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.